Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to tame chemo symptoms for breast cancer patients

NCT ID NCT07495358

Symptom relief Sponsor: Capital Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a smartphone-based system that gives personalized advice to breast cancer patients going through chemotherapy. The system uses a knowledge graph to combine medical guidelines and patient-reported symptoms. Thirty patients and their nurses will use the system to see if it is easy to use and helpful for managing side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Knowledge graph-based symptom management recommendation system (behavioral intervention)
What this could lead to
If it works, this could give breast cancer patients a simple way to get personalized advice for managing chemotherapy side effects, potentially improving their daily comfort.
What could go wrong
This is a very small, early-stage usability study with only 30 people. It focuses on whether the system is easy to use, not on proving it improves health outcomes. The system may not work for everyone or may not reduce symptoms significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 to 80 years * Pathologically confirmed breast cancer * Stage I-III breast cancer * Planning to initiate or currently receiving neoadjuvant or adjuvant chemotherapy * Expected to continue chemotherapy during the study period and complete at least two treatment time points/cycles * Able and willing to provide informed consent * Able to complete basic smartphone operations and system tasks independently or with guidance from the research staff Exclusion Criteria: * Recurrent or metastatic breast cancer (stage IV) * Significant cognitive impairment or communication barriers that preclude informed consent or completion of study procedures * Severe psychiatric disorders or unstable psychiatric symptoms that may interfere with study participation * Considered unsuitable for participation by the clinical or research team because of unstable medical condition or need for acute management

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm syndromic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast neoplasms Syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.